← Open Payments lookup

MICHAEL MOTISE-PACIER: Open Payments

NPI 1659822849 · WOODSTOCK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,853 in 95 payments from 12 companies in 2025. Trend: 2023 $1,499 · 2024 $1,826 · 2025 $1,853

Food & beverage: $1,849Education: $4
CompanyPaymentsAmount
ABBVIE INC.37$539
Neurocrine BioSciences, Inc.12$300
Teva Pharmaceuticals USA, Inc.11$285
Otsuka America Pharmaceutical, Inc.12$201
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$152
Janssen Pharmaceuticals, Inc5$130
Takeda Pharmaceuticals U.S.A., Inc.3$84
Otsuka Pharmaceutical Development & Commercialization, Inc.3$68
Boehringer Ingelheim Pharmaceuticals, Inc.1$29
Alkermes, Inc.1$24

Products named: VRAYLAR, INGREZZA, AUSTEDO XR, CAPLYTA, REXULTI, INVEGA SUSTENNA, TRINTELLIX, REJOYN.

Industry payments across NY — which companies pay providers there.